Research Article

Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients

Table 3

GMD/WMD comparison between autoantibody-positive and -negative patients.

AB-positive patient AB-negative patient
MeanSDMeanSD

U1RNP = 30 = 65
 GMD0.53720.02720.54870.0237−2.095
 WMD0.51520.02020.51970.0271−0.8050.423
Sm = 45 = 50
 GMD0.53730.02630.55200.0223−2.938
 WMD0.51470.02470.52150.0253−1.3210.190
ACL = 33 = 39
 GMD0.53720.02270.54830.0226−1.8940.062
 WMD0.51350.03010.52610.0184−2.186
SSB = 34 = 61
 GMD0.54520.02520.54490.02550.0490.961
 WMD0.51050.02770.52260.0227−2.313
SSA52 = 51 = 44
 GMD0.54640.02430.54340.02660.5640.574
 WMD0.51370.02570.52360.0238−1.9360.056
SSA60 = 61 = 34
 GMD0.54710.02350.54130.02811.0700.288
 WMD0.51620.02460.52210.0261−1.1100.270
Histone = 51 = 44
 GMD0.54040.02130.55040.0228−1.9340.056
 WMD0.51340.02540.52250.02441.7810.078
P0 = 46 = 49
 GMD0.54560.02710.54450.02370.2180.828
 WMD0.51690.02760.51960.0228−0.5100.611
Nucleosome = 38 = 57
 GMD0.54180.02790.54720.0234−1.0190.311
 WMD0.52000.02510.51710.02530.5490.584
DsDNA = 63 = 32
 GMD0.54340.02740.54830.02060.8990.371
 WMD0.51530.02330.52410.02791.6130.110

AB: antibodies; ACL: anticardiolipin antibodies; histone: antihistone antibodies; P0: antiribosomal P antibodies; SM: Anti-Sm antibodies; ds-DNA: anti-dsDNA antibodies; SSA52: anti-Ro/SSA 52-KD antibodies; SSA60: anti-Ro/SSA 60-KD antibodies; SSB: anti-La/SSB antibodies; U1RNP: anti-U1 RNP antibodies; nucleosome: antinucleosome antibodies; < 0.05, < 0.01.